Rumunsko - rumunština - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

abbvie s.r.l. - italia - paricalcitolum - sol. inj. - 5micrograme/ml - preparate antihormoni paratiroidieni medicamente antihormoni paratiroidieni

Německo - němčina - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

abbvie deutschland gmbh & co. kg - zweigniederlassung - (8146051) - paricalcitol - injektionslösung - teil 1 - injektionslösung; paricalcitol (33932) 5 mikrogramm

Singapur - angličtina - HSA (Health Sciences Authority)

abbvie pte. ltd. - paricalcitol - injection - 5 mcg/ml - paricalcitol 5 mcg/ml

Spojené státy - angličtina - NLM (National Library of Medicine)

abbvie inc. - paricalcitol (unii: 6702d36og5) (paricalcitol - unii:6702d36og5) - paricalcitol 2 ug in 1 ml - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism in patients 5 years of age and older with chronic kidney disease (ckd) on dialysis. zemplar is contraindicated in patients with: - hypercalcemia [see warnings and precautions ( 5.1 )] - vitamin d toxicity [see warnings and precautions ( 5.1 )] - known hypersensitivity to paricalcitol or any of the inactive ingredients in zemplar. hypersensitivity adverse reactions have been reported [e.g., angioedema (including laryngeal edema) and urticaria] [see adverse reactions ( 6.2 )] . risk summary limited data with zemplar in pregnant women are insufficient to inform a drug-associated risk for major birth defects and miscarriage. there are risks to the mother and fetus associated with chronic kidney disease in pregnancy (see clinical considerations ) . in animal reproduction studies, slightly increased embryofetal loss was observed in pregnant rats and rabbits administered paricalcitol intravenously during the period of organogenes

Španělsko - španělština - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

abbvie spain, s.l.u. - paricalcitol - soluciÓn inyectable - 5 microgramos - paricalcitol 5 microgramos - paricalcitol

Španělsko - španělština - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

abbvie spain, s.l.u. - paricalcitol - soluciÓn inyectable - 2 microgramos - paricalcitol 2 microgramos - paricalcitol

Švédsko - švédština - Läkemedelsverket (Medical Products Agency)

abbvie ab - parikalcitol - injektionsvätska, lösning - 5 mikrogram/ml - propylenglykol hjälpämne; parikalcitol 5 mikrog aktiv substans; etanol, vattenfri hjälpämne - parikalcitol

Nizozemsko - nizozemština - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

abbvie b.v. wegalaan 9 2132 jd hoofddorp - paricalcitol - oplossing voor injectie - ethanol 158 mg/ml ; propyleenglycol (e 1520) 312 mg/ml ; water voor injectie, - paricalcitol

Moldavsko - rumunština - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

abbvie biopharmaceuticals gmbh - paracalcitolum - soluţie injectabilă - 5 mcg/ml

Portugalsko - portugalština - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

abbvie, lda. - paricalcitol - solução injetável - 2 µg/ml - paricalcitol 2 µg/ml - paricalcitol - n/a - duração do tratamento: longa duração